AAAAAA

   
Results: 1-13 |
Results: 13
Widespread cutaneous carcinomas associated with human papillomaviruses 5, 14 and 20 after introduction of methotrexate in two long-term PUVA-treated patients
Authors: Zumtobel, U Schwarze, HP Favre, M Taieb, A Delaunay, M
Citation: U. Zumtobel et al., Widespread cutaneous carcinomas associated with human papillomaviruses 5, 14 and 20 after introduction of methotrexate in two long-term PUVA-treated patients, DERMATOLOGY, 202(2), 2001, pp. 127-130
Economic analysis of adjuvant therapy with interferon alpha-2a in stage IImalignant melanoma
Authors: Lafuma, A Dreno, B Delaunay, M Emery, C Fagnani, F Hieke, K Bonerandi, JJ Grob, JJ
Citation: A. Lafuma et al., Economic analysis of adjuvant therapy with interferon alpha-2a in stage IImalignant melanoma, EUR J CANC, 37(3), 2001, pp. 369-375
Evidence that an identical T cell clone in Skin and peripheral blood lymphocytes is an independent prognostic factor in primary cutaneous T cell lymphomas
Authors: Beylot-Barry, M Sibaud, V Thiebaut, R Vergier, B Beylot, C Delaunay, M Chene, G Dubus, P Merlio, JP
Citation: M. Beylot-barry et al., Evidence that an identical T cell clone in Skin and peripheral blood lymphocytes is an independent prognostic factor in primary cutaneous T cell lymphomas, J INVES DER, 117(4), 2001, pp. 920-926
White blood cell count: A prognostic factor and possible subset indicator of optimal treatment with low-dose adjuvant interferon in primary melanoma
Authors: de La Salmoniere, P Grob, JJ Dreno, B Delaunay, M Chastang, C
Citation: P. De La Salmoniere et al., White blood cell count: A prognostic factor and possible subset indicator of optimal treatment with low-dose adjuvant interferon in primary melanoma, CLIN CANC R, 6(12), 2000, pp. 4713-4718
Photoionization of highly charged ions using an ECR ion source and undulator radiation
Authors: Bizau, JM Esteva, JM Cubaynes, D Wuilleumier, FJ Blancard, C La Fontaine, AC Couillaud, C Lachkar, J Marmoret, R Remond, C Bruneau, J Hitz, D Ludwig, P Delaunay, M
Citation: Jm. Bizau et al., Photoionization of highly charged ions using an ECR ion source and undulator radiation, PHYS REV L, 84(3), 2000, pp. 435-438
Delays in diagnosis and melanoma prognosis (I): The role of patients
Authors: Richard, MA Grob, JJ Avril, MF Delaunay, M Gouvernet, J Wolkenstein, P Souteyrand, P Dreno, B Bonerandi, JJ Dalac, S Machet, L Guillaume, JC Chevrant-Breton, J Vilmer, C Aubin, F Guillot, B Beylot-Barry, M Lok, C Raison-Peyron, N Chemaly, P
Citation: Ma. Richard et al., Delays in diagnosis and melanoma prognosis (I): The role of patients, INT J CANC, 89(3), 2000, pp. 271-279
Delays in diagnosis and melanoma prognosis (II): The role of doctors
Authors: Richard, MA Grob, JJ Avril, MF Delaunay, M Gouvernet, J Wolkenstein, P Souteyrand, P Dreno, B Bonerandi, JJ Dalac, S Machet, L Guillaume, JC Chevrant-Breton, J Vilmer, C Aubin, F Guillot, B Beylot-Barry, M Lok, C Raison-Peyron, N Chemaly, P
Citation: Ma. Richard et al., Delays in diagnosis and melanoma prognosis (II): The role of doctors, INT J CANC, 89(3), 2000, pp. 280-285
Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases
Authors: Vergier, B de Muret, A Beylot-Barry, M Vaillant, L Ekouevi, D Chene, G Carlotti, A Franck, N Dechelotte, P Souteyrand, P Courville, P Joly, P Delaunay, M Bagot, M Grange, F Fraitag, S Bosq, J Petrella, T Durlach, A De Mascarel, A Merlio, JP Wechsler, J
Citation: B. Vergier et al., Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases, BLOOD, 95(7), 2000, pp. 2212-2218
Labelling of medicinal products: Regulations and practical aspects
Authors: Clement, F Auduc, C Baraffe, P Bourdelet, A Cotty, J Delaunay, M de Saint-Seine, B Dupin-Spriet, T Flouvat, E Gosselin, P Klotz-Masson, C Launois, X Sachot, C Tibi, A Torterotot, C Touchard, F
Citation: F. Clement et al., Labelling of medicinal products: Regulations and practical aspects, STP PHARM S, 9(2), 1999, pp. 181-186
The spectrum of cutaneous lymphomas in HIV infection - A study of 21 cases
Authors: Beylot-Barry, M Vergier, B Masquelier, B Bagot, M Joly, P Souteyrand, P Vaillant, L Avril, MF Franck, N Fraitag, S Delaunay, M Laroche, L Esteve, E Courville, P Dechelotte, P Beylot, C De Mascarel, A Wechsler, J Merlio, JP
Citation: M. Beylot-barry et al., The spectrum of cutaneous lymphomas in HIV infection - A study of 21 cases, AM J SURG P, 23(10), 1999, pp. 1208-1216
Toxicity and feasibility of adjuvant high dose interferon alpha-2b in patients with melanoma in clinical oncologic practice
Authors: Ravaud, A Bedane, C Geoffrois, L Lesimple, T Delaunay, M
Citation: A. Ravaud et al., Toxicity and feasibility of adjuvant high dose interferon alpha-2b in patients with melanoma in clinical oncologic practice, BR J CANC, 80(11), 1999, pp. 1767-1769
Melanoma and tumor thickness - Challenges of early diagnosis
Authors: Richard, MA Grob, JJ Avril, MF Delaunay, M Thirion, X Wolkenstein, P Souteyrand, P Dreno, B Bonerandi, JJ Dalac, S Machet, L Guillaume, JC Chevrant-Breton, J Vilmer, C Aubin, F Guillot, B Beylot-Barry, M Lok, C Raison-Peyron, N Chemaly, P
Citation: Ma. Richard et al., Melanoma and tumor thickness - Challenges of early diagnosis, ARCH DERMAT, 135(3), 1999, pp. 269-274
A prospective study of cutaneous intolerance to topical mechlorethamine therapy in patients with cutaneous T-cell lymphomas
Authors: Esteve, E Bagot, M Joly, P Souteyrand, P Beylot-Barry, M Vaillant, L Delaunay, M Avril, MF Laroche, L Grange, F Thomine, E Wechsler, J
Citation: E. Esteve et al., A prospective study of cutaneous intolerance to topical mechlorethamine therapy in patients with cutaneous T-cell lymphomas, ARCH DERMAT, 135(11), 1999, pp. 1349-1353
Risultati: 1-13 |